Send your queries and feedback on this paper by contacting the author.
There is a lack of clinical data on the validity of neoadjuvant chemotherapy in the treatment of ovarian cancer. The aim of this study was to compare the impact of the adjuvant and neoadjuvant chemotherapy regimens on the clinical outcomes in patients with advanced ovarian cancer.
Reprinted with Permission from http://www.biomedcentral.com
:: IDS Emergency Management :: IDS Water ::IDS Publishing / Media::IDS Packaging::IDS Environment::IDS Plastics::IDS Power/Energy::
IDS, Inc. – Online Tradeshow, Exhibition, & Buyers Guide Solutions